Next Article in Journal
Metabolomic Profiling Reveals the Anti-Herbivore Mechanisms of Rice (Oryza sativa)
Previous Article in Journal
Application of TSPO-Specific Positron Emission Tomography Radiotracer as an Early Indicator of Acute Liver Failure Induced by Propacetamol, a Prodrug of Paracetamol
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Petanin Potentiated JNK Phosphorylation to Negatively Regulate the ERK/CREB/MITF Signaling Pathway for Anti-Melanogenesis in Zebrafish

1
Qinghai Provincial Key Laboratory of Tibetan Medicine Research and CAS Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Xining 810008, China
2
Huzhou China-Science Innovation Centre of Plateau Biology, Huzhou 313000, China
3
University of Chinese Academy of Sciences, Beijing 100049, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(11), 5939; https://doi.org/10.3390/ijms25115939
Submission received: 8 April 2024 / Revised: 22 May 2024 / Accepted: 24 May 2024 / Published: 29 May 2024
(This article belongs to the Section Bioactives and Nutraceuticals)

Abstract

Petanin, an acylated anthocyanin from the Solanaceae family, shows potential in tyrosinase inhibitory activity and anti-melanogenic effects; however, its mechanism remains unclear. Therefore, to investigate the underlying mechanism of petanin’s anti-melanogenic effects, the enzyme activity, protein expression and mRNA transcription of melanogenic and related signaling pathways in zebrafish using network pharmacology, molecular docking and molecular dynamics simulation were combined for analysis. The results showed that petanin could inhibit tyrosinase activity and melanogenesis, change the distribution and arrangement of melanocytes and the structure of melanosomes, reduce the activities of catalase (CAT) and peroxidase (POD) and enhance the activity of glutathione reductase (GR). It also up-regulated JNK phosphorylation, inhibited ERK/RSK phosphorylation and down-regulated CREB/MITF-related protein expression and mRNA transcription. These results were consistent with the predictions provided through network pharmacology and molecular docking. Thus, petanin could inhibit the activity of tyrosinase and the expression of tyrosinase by inhibiting and negatively regulating the tyrosinase-related signaling pathway ERK/CREB/MITF through p-JNK. In conclusion, petanin is a good tyrosinase inhibitor and anti-melanin natural compound with significant market prospects in melanogenesis-related diseases and skin whitening cosmetics.
Keywords: acylated anthocyanins; tyrosinase inhibitor; anti-melanogenesis; network pharmacology; MAPKs acylated anthocyanins; tyrosinase inhibitor; anti-melanogenesis; network pharmacology; MAPKs
Graphical Abstract

Share and Cite

MDPI and ACS Style

Ouyang, J.; Hu, N.; Wang, H. Petanin Potentiated JNK Phosphorylation to Negatively Regulate the ERK/CREB/MITF Signaling Pathway for Anti-Melanogenesis in Zebrafish. Int. J. Mol. Sci. 2024, 25, 5939. https://doi.org/10.3390/ijms25115939

AMA Style

Ouyang J, Hu N, Wang H. Petanin Potentiated JNK Phosphorylation to Negatively Regulate the ERK/CREB/MITF Signaling Pathway for Anti-Melanogenesis in Zebrafish. International Journal of Molecular Sciences. 2024; 25(11):5939. https://doi.org/10.3390/ijms25115939

Chicago/Turabian Style

Ouyang, Jian, Na Hu, and Honglun Wang. 2024. "Petanin Potentiated JNK Phosphorylation to Negatively Regulate the ERK/CREB/MITF Signaling Pathway for Anti-Melanogenesis in Zebrafish" International Journal of Molecular Sciences 25, no. 11: 5939. https://doi.org/10.3390/ijms25115939

APA Style

Ouyang, J., Hu, N., & Wang, H. (2024). Petanin Potentiated JNK Phosphorylation to Negatively Regulate the ERK/CREB/MITF Signaling Pathway for Anti-Melanogenesis in Zebrafish. International Journal of Molecular Sciences, 25(11), 5939. https://doi.org/10.3390/ijms25115939

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop